Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Tegafur 2Leucovorin 2Immunoenzyme Techniques 2vandetanib 1temsirolimus 1soblidotin 1Temozolomide 1Polymerase Chain Reaction 1Paclitaxel 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Immunization, Passive 1Gemcitabine 1Etoposide 1Drug Therapy 1Antibodies, Monoclonal 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Unspecified Adult Solid Tumor, Protocol Specific × soblidotin × Clear all
NCT00072228 2013-07-10

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

National Cancer Institute (NCI)

Phase 1 Withdrawn
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡